Mark Byrne

Former affiliation

Full Professor, Biomedical Engineering

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Chemical Engineering, doctorate

Chemical Engineering, Master

Fingerprint

Dive into the research topics where Mark Byrne is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished

Development and Characterization of Novel Silicone Hydrogel Lens Materials
Byrne, M.
Gelest, Inc.
9/1/18 → 7/31/19
Project: Other project
Novel In-Situ Forming Biodegradable Nanogels Killing Myo/Nog Cells in the Lens to Prevent the Fibrotic Disease called Posterior Capsule Opacification (PCO)
Byrne, M.
The Cooper Foundation
6/1/17 → 5/31/20
Project: Other project

2439 Citations
25 h-Index
33 Article
13 Conference contribution
12 Review article
4 Paper
More

Amphiphilic PLGA-PEG-PLGA triblock copolymer nanogels varying in gelation temperature and modulus for the extended and controlled release of hyaluronic acid
Osorno, L. L., Maldonado, D. E., Whitener, R. J., Brandley, A. N., Yiantsos, A., Medina, J. D. R. & Byrne, M. E., Jul 5 2020, In: Journal of Applied Polymer Science. 137, 25, 48678.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Extended Release of Doxorubicin-Loaded 3DNA Nanocarriers from In-Situ Forming, Self-Assembled Hydrogels
Osorno, L. L., Medina, J. D. R., Maldonado, D. E., Mosley, R. J. & Byrne, M. E., Jul 1 2020, In: Journal of Ocular Pharmacology and Therapeutics. 36, 6, p. 447-457 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Nucleic acid biohybrid nanocarriers with high-therapeutic payload and controllable extended release of daunomycin for cancer therapy
Whitener, R., Mosley, R. J., Wower, J. & Byrne, M. E., 2020, (Accepted/In press) In: Journal of Biomedical Materials Research - Part A.
Research output: Contribution to journal › Article › peer-review
Emerging therapies for neuropathic lysosomal storage disorders
Kelly, J. M., Bradbury, A., Martin, D. R. & Byrne, M. E., May 1 2017, In: Progress in Neurobiology. 152, p. 166-180 15 p.
Research output: Contribution to journal › Review article › peer-review
13 Scopus citations
Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapy
Kelly, J. M., Gross, A. L., Martin, D. R. & Byrne, M. E., Dec 2017, In: Nanomedicine. 12, 23, p. 2591-2606 16 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations

Education/Academic qualification

Development and Characterization of Novel Silicone Hydrogel Lens Materials

Novel In-Situ Forming Biodegradable Nanogels Killing Myo/Nog Cells in the Lens to Prevent the Fibrotic Disease called Posterior Capsule Opacification (PCO)

Amphiphilic PLGA-PEG-PLGA triblock copolymer nanogels varying in gelation temperature and modulus for the extended and controlled release of hyaluronic acid

Extended Release of Doxorubicin-Loaded 3DNA Nanocarriers from In-Situ Forming, Self-Assembled Hydrogels

Nucleic acid biohybrid nanocarriers with high-therapeutic payload and controllable extended release of daunomycin for cancer therapy

Emerging therapies for neuropathic lysosomal storage disorders

Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapy